Exercise and Type 2 Diabetes - OHSU

12 downloads 0 Views 4MB Size Report
College of Health and Human Services. San Diego State University. Portland ..... uc tio n. 0. –10. –20. –30. –40. –50. Deaths. Related to. Diabetes. All-Cause.
Exercise and Type 2 Diabetes

Larry S. Verity, PhD, FACSM School of Exercise & Nutritional Sciences College of Health and Human Services San Diego State University

Characteristics of Type 1 & Type 2 Diabetes Mellitus

Portland 2011 - T2DM

1

Rate of New Cases of Type 1 & Type 2 Diabetes among Youth < 20 yrs

Portland 2011 - T2DM

Estimated Growth in Type 2 Diabetes: US Population From 2000-2050 Type 2 DM

General population

Working age population (20-59)

120

Percent increase

100 80 60 40 20 0

2000 2005 2010 2015 2020 2025 2030 2035 2040 2045 2050

Year Bagust A, et al. Diabetes, 50 [Suppl 2], A205, 2001 Portland 2011 - T2DM

2

Age-adjusted % of U.S. Adults Who Were Obese or Who Had Diagnosed Diabetes Obesity (BMI ≥30 kg/m2) 1994

No Data

26.0%

Diabetes 1994

No Data

2009

2000

9.0%

CDC‟s Division of Diabetes Translation. National Diabetes Surveillance System available at http://www.cdc.gov/diabetes/statistics

Portland 2011 - T2DM

Diabetes Prevalence: Age and Ethnicity 20-39

40-49

50-59

60-74

75+

25

Percentage (%)

20 15 10 5 0 White - NH

Black - NH

Hispanic

Native Am/Al

Portland 2011 - T2DM

3

Natural History of Type 2 Diabetes Years from diagnosis

-10

0

-5

Onset

10

5

15

Diagnosis

Insulin resistance Insulin secretion

Postprandial glucose Fasting glucose

Microvascular complications

Macrovascular complications (65% die of CVD) Pre-diabetes Type 2 diabetes Ramlo-Halsted BA, Edelman SV. Prim Care. 1999;26:771-789; Nathan DM. N Engl J Med. 2002;347:1342-1349

Portland 2011 - T2DM

Stages of Type 2 Diabetes 100

MonoTherapy

75

b-Cell Function (% b)

Combination Oral Therapy

50

Type 2 Diabetes Phase I Type 2 Diabetes Phase II

25

0 -12 -10

-6

-2

0

2

6

Insulin Phase III 10

14

Years From Diagnosis Portland 2011 - T2DM

Based on data of UKPDS 16: Diabetes. 1995.

4

Cardiometabolic Risk - Graphic Overweight / Obesity Age

Genetics

Insulin Resistance Insulin Resistance ? Syndrome Lipids BP Glucose

Abnormal Lipid Metabolism LDL ApoB HDL Trigly.

Cardiometabolic Risk Global Diabetes / CVD Risk

Age, Race, Gender, Family History

Smoking Inflammation Hypercoagulation

Unhealthy Eating Physical Inactivity

Hypertension

Proportion of Patients with Cardiovascular Disease Increases with Duration of Diabetes 48%

29% 21%

24%

15%

≤2

3-5

6-9

10-14

15+

Years after DM Diagnosis Harris, S et al.; Type 2 Diabetes and Associated Complications in Primary Care in Canada: The Impact of Duration of Disease on Morbidity Load. CDA 2003. Portland 2011 - T2DM

5

Contemporary Diabetes Care Team Approach Physician(s) Diabetologist

Exercise Professional

Management Team Diabetes Educator

Registered Dietician

Portland 2011 - T2DM

Management of Diabetes Mellitus: Therapeutic Steps in Management • Medical management • Use of medications to manage glucose • oral agents and/or • insulin

Portland 2011 - T2DM

• Frequent monitoring of blood glucose • Proper diet and exercise

6

Mechanisms of Action of Pharmacologic Agents for Diabetes

Portland 2011 - T2DM

Summary of Pharmacologic Incretin Actions on Different Target Tissues Heart

Brain

Neuroprotection Appetite

Stomach Gastric Emptying

Cardioprotection Cardiac Output

GLP-1

_

Liver

GI Tract

Insulin Secretion β-Cell Neogenesis

Glucose Production Drucker DJ, Cell Metab. 2006;3:153-165. Portland 2011 - T2DM

Muscle

+

β-Cell Apoptosis

Glucose Uptake

Glucagon Secretion

7

Exercise + Lifestyle Benefits • • • • •

 insulin sensitivity  of diabetes medications  glucose control for type 2 Predictor of successful weight management Aids in managing other Cardiometabolic risks • Hypertension • Dyslipidemia • Obesity, Body weight/fat and morphology

• Psychoemotional benefits • Anxiety, Depression, Self-esteem Portland 2011 - T2DM

Diabetes Prevention Program [DPP]:

Preventive Strategies?

Clinical trials examined prevention of type 2 diabetes LIFESTYLE was very effective Physical activity > 150 mins/wk MNT for diabetes Strategies for success

Is the DPP an effective „model‟ for secondary prevention? Portland 2011 - T2DM

8

Diabetes Incidence Rates by Ethnicity

Cases/100 person-yr

Lifestyle

Metformin

Placebo

12

8

4

0 Caucasian (n=1768)

African American (n=645)

Hispanic (n=508)

American Indian (n=171)

Asian (n=142)

The DPP Research Group, NEJM 346:393-403, 2002

Portland 2011 - T2DM

Diabetes Incidence Rates by BMI Cases/100 person-yr

16

Lifestyle

Metformin

Placebo

12 8 4 0

24 < 30

30 < 35

(n=1045)

(n=995)

> 35 (n=1194)

Body Mass Index (kg/m2) Portland 2011 - T2DM

The DPP Research Group, NEJM 346:393-403, 2002

9

DPP: Weight Loss and Physical Activity Placebo

Metformin

Lifestyle P 1,500 - 2,000 At least 150 mins/wk

Type (aerobic)

Resistance Frequency > 3 d/wk

Intensity

moderate

Repetitions

8-10 per exercise

Sets

> 3 sets per exercise

Type

major muscle groups: 810 exercises

Portland 2011 - T2DM

10

Association Between Insulin Sensitivity and Physical Exercise: The IRAS Study

Portland 20112011 - T2DM ACE Mtng

Portland 20112011 - T2DM ACE Mtng

11

Effect of Physical Activity on Glucose Control HbA1c % is lowered

10

HbA1c (%)

9.5 9 8.5

WMD = -0.66; p